December 18, 2017 / 6:11 AM / 6 months ago

BRIEF-Targovax: TG02 Passes Initial Safety Review In First-In-Man Clinical Trial In Colorectal Cancer

Dec 18 (Reuters) - Targovax ASA:

* REG-TARGOVAX ANNOUNCES THAT TG02 HAS PASSED THE INITIAL SAFETY REVIEW IN THE FIRST-IN-MAN CLINICAL TRIAL IN COLORECTAL CANCER Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below